 BrainsWay Ltd. NASDAQ TASE: BWAY BrainsWay, a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation producats using the Companys proprietary Deep Transcranial Magnetic Stimulation dTMS technology for the treatment of major depressive disorder MDD and Obsessive Compulsive Disorder OCD, announced today that Mr. Avner Lushi will be joining its board of directors and will also serve as a member of its audit committee. The announcement comes after the recent shareholder approval of his election to the board. 